S
Seok Yun Kang
Researcher at Ajou University
Publications - 117
Citations - 1625
Seok Yun Kang is an academic researcher from Ajou University. The author has contributed to research in topics: Cancer & Breast cancer. The author has an hindex of 22, co-authored 106 publications receiving 1280 citations.
Papers
More filters
Journal ArticleDOI
Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer
Min Hee Ryu,Changhoon Yoo,Jong Gwang Kim,Baek Yeol Ryoo,Young Soo Park,Sook Ryun Park,Hye Suk Han,Ik Joo Chung,Eun Kee Song,Kyung Hee Lee,Seok Yun Kang,Yoon-Koo Kang +11 more
TL;DR: Combination of trastuzumab and XELOX is well tolerated and highly effective in patients with HER2-positive AGC.
Journal ArticleDOI
Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2 trial
Yeon Hee Park,Tae-Yong Kim,Gun Min Kim,Seok Yun Kang,In Hae Park,Jee Hyun Kim,Kyoung Eun Lee,Hee Kyung Ahn,Moon Hee Lee,Hee-Jun Kim,Han Jo Kim,Jong In Lee,Su-Jin Koh,Ji-Yeon Kim,Kyung-Hun Lee,Joohyuk Sohn,Sung Bae Kim,Jin-Seok Ahn,Young-Hyuck Im,Kyung Hae Jung,Seock-Ah Im,HK Ahn,EK Cho,IH Park,KS Lee,SS Sim,SJ Hong,MH Chang,JH Kim,YJ Kim,Seog-Young Kim,KJ Suh,YH Park,Woong-Yang Park,YL Choi,JH Yu,YH Im,Jin Seok Ahn,Jy Hur,SH Park,Jy Kim,SJ Nam,Je Lee,Sang We Kim,SK Lee,Sa Im,Kim,Tae-You Kim,DY Oh,KH Lee,DW Lee,HJ Kim,HJ Kim,KH Jung,Sung-Bae Kim,JH Ahn,Je Kim,JH Jung,Sy Kang,Ahn,YW Choi,GM Kim,JH Sohn,MH Kim,SJ Koh,JK Cheon,Ji Lee,ST Lim,Sy Hyun,Ke Lee,MH Lee,JH Cho,JH Lim +72 more
TL;DR: Exemestane plus palbociclib plus endocrine therapy with ovarian function suppression showed clinical benefit compared with capecitabine in terms of improved progression-free survival in premenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer.
Journal ArticleDOI
Differential Diagnosis in Idiopathic Granulomatous Mastitis and Tuberculous Mastitis
Hee Ri Na Seo,Kuk Young Na,Hyunee Yim,Tae Hee Kim,Doo Kyoung Kang,Ki Keun Oh,Seok Yun Kang,Young-Sil An,Mison Chun,Woojae Kim,Rae Woong Park,Yong Sik Jung,Ku Sang Kim +12 more
TL;DR: The IGM patients were younger and had more mastalgia symptoms than the TM patients, and surgical wide excision might be both therapeutic and useful for providing an exact diagnosis.
Journal ArticleDOI
Efficacy, Safety, and Tolerability of Pertuzumab, Trastuzumab, and Docetaxel for Patients With Early or Locally Advanced ERBB2-Positive Breast Cancer in Asia: The PEONY Phase 3 Randomized Clinical Trial.
Zhimin Shao,Da Pang,Hongjian Yang,Wei Li,Shusen Wang,Shude Cui,Ning Liao,Yongsheng Wang,Chuan Wang,Yuan Ching Chang,Hweichung Wang,Seok Yun Kang,Jae Hong Seo,Kunwei Shen,Suphawat Laohawiriyakamol,Zefei Jiang,Junjie Li,Julian Zhou,Betsy Althaus,Yixiang Mao,Yixiang Mao,Jennifer Eng-Wong +21 more
TL;DR: Treatment with pertuzumab, trastuzumabs, and docetaxel resulted in a statistically significant improvement in the total pathologic complete response rate vs placebo, trASTuzumAB, andDocetaxe for the neoadjuvant treatment of ERBB2-positive early or locally advanced breast cancer in Asian patients.
Journal ArticleDOI
Phase III, Multicenter, Randomized Trial of Maintenance Chemotherapy Versus Observation in Patients With Metastatic Breast Cancer After Achieving Disease Control With Six Cycles of Gemcitabine Plus Paclitaxel As First-Line Chemotherapy: KCSG-BR07-02
Yeon Hee Park,Kyung Hae Jung,Seock-Ah Im,Joohyuk Sohn,Jungsil Ro,Jin-Hee Ahn,Sung Bae Kim,Byung-Ho Nam,Do Youn Oh,Sae-Won Han,Soohyeon Lee,In Hae Park,Keun Seok Lee,Jee Hyun Kim,Seok Yun Kang,Moon Hee Lee,Hee Sook Park,Jin Seok Ahn,Young-Hyuck Im +18 more
TL;DR: In patients with MBC who achieved disease control with an initial six cycles of PG chemotherapy, maintenance PG chemotherapy resulted in better PFS and OS compared with observation.